Search

everythinglearnresearchcommunity

for

Search:↓

Telogen effluvium is common after symptomatic COVID-19, especially in young females, and may be linked to nutritional deficiencies.

Telogen Effluvium (TE) significantly affects women due to stress and hormonal changes, requiring better public health policies and mental health support.

Hair loss at the site where hair was taken for a transplant can be due to the normal hair growth cycle.

COVID-19 infection is linked to temporary hair loss in Egyptian women.

A man had temporary hair loss after a spinal cord injury, with some permanent thinning remaining.

The woman's hair loss is likely stress-related and should improve without treatment.

Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.

Anagen effluvium is a reversible condition causing sudden hair loss, often due to chemotherapy or head radiation.

Reassurance and counseling are key in managing acute telogen effluvium, with supplements possibly offering a placebo effect.

Effective anesthesia strategies can help minimize hair loss in patients with telogen effluvium during surgery.

The author suggests changing "telogen effluvium" to "telogen defluxion" for hair loss terminology.

Telogen effluvium is linked to deficiencies in iron, vitamin B12, and thyroid function.

Some medications, including retinoids, antifungals, and psychotropic drugs, can cause reversible hair loss if stopped or doses are reduced.

Hair loss after childbirth is more common in women who have had multiple births, cesarean deliveries, significant weight gain, and full-term pregnancies.

Individualized homeopathic treatment led to complete hair regrowth in a patient with stress-induced hair loss.

Post-COVID-19 patients are at risk for hair loss.

A man's hair grew back to almost normal 7 months after COVID-19 without needing treatment.

Most lab tests for patients with Telogen effluvium, a type of hair loss, show no or mild abnormalities; only a few specific tests are useful.

Telogen effluvium increased globally after COVID-19, especially in Asian and Latin regions.

Serum ferritin can help diagnose Telogen Effluvium.

Hair loss can happen after severe H1N1 flu but usually grows back in 4 months.

COVID-19 can cause temporary hair loss in some patients, affecting their quality of life.

Hair transplant surgery can cause temporary hair loss in the area where hair was taken from.

The study found that it's hard to tell the difference between two types of hair loss, alopecia areata and telogen effluvium, by looking at symptoms and tissue samples.

CTE and FPHL are different hair loss types with unique causes.

Combining PRP with Tressfix Serum is more effective for hair regrowth in telogen effluvium than using either alone.

Monocytes might be linked to hair loss after COVID-19.

Manage hair shedding by identifying triggers, possibly using supplements or medications, and tracking with a health calendar.

COVID-19 infection can cause temporary hair loss due to stress, treatment drugs, psychological impact, and pandemic-related stress.

Hair loss may be an early sign of serious illnesses like Hodgkin disease.